Hypomorphic nuclear factor-κB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity

Journal of Allergy and Clinical Immunology

Volumn 122, Issue 6, 2008, Pages

  Hanson, Eric P ^a   Monaco Shawver, Linda ^a   Solt, Laura A ^b   Madge, Lisa A ^b   Banerjee, Pinaki P ^a   May, Michael J ^b   Orange, Jordan S ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA SCHOOL OF VETERINARY MEDICINE   (United States)

Author keywords

A20; genetic database; immunodeficiency; Jurkat reconstitution; NEMO; NF B activation

Indexed keywords

CD40 ANTIGEN; I KAPPA B; I KAPPA B KINASE GAMMA; INTERLEUKIN 1; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 5; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ALBERS SCHOENBERG DISEASE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ECTODERMAL DYSPLASIA; ENZYME RECONSTITUTION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE MUTATION; GENETIC COMPLEMENTATION; GENOTYPE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHEDEMA; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIOSIS; OUTCOME ASSESSMENT; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; SMALL FOR DATE INFANT; ZINC FINGER MOTIF;

EID: 57149141634     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.08.018     Document Type: Article

References (35)

1. Aradhya S., Bardaro T., Galgoczy P., Yamagata T., Esposito T., Patlan H., et al. Multiple pathogenic and benign genomic rearrangements occur at a 35 kb duplication involving the NEMO and LAGE2 genes. Hum Mol Genet 10 (2001) 2557-2567
2. Gilmore T.D. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 25 (2006) 6680-6684
3. Zonana J., Elder M.E., Schneider L.C., Orlow S.J., Moss C., Golabi M., et al. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am J Hum Genet 67 (2000) 1555-1562
4. Doffinger R., Smahi A., Bessia C., Geissmann F., Feinberg J., Durandy A., et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet 27 (2001) 277-285
5. Jain A., Ma C.A., Liu S., Brown M., Cohen J., and Strober W. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol 2 (2001) 223-228
6. He K.L., and Ting A.T. A20 inhibits tumor necrosis factor (TNF) α-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells. Mol Cell Biol 22 (2002) 6034-6045
7. Swift S., Lorens J., Achacoso P., and Nolan G.P. Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. Curr Protoc Immunol 31 (2001) 14-29
8. Pandey R., Destephan C.M., Madge L.A., May M.J., and Orange J.S. NKp30 ligation induces rapid activation of the canonical NF-κB pathway in NK cells. J Immunol 179 (2007) 7385-7396
9. Marienfeld R.B., Palkowitsch L., and Ghosh S. Dimerization of the I kappa B kinase-binding domain of NEMO is required for tumor necrosis factor alpha-induced NF-kappa B activity. Mol Cell Biol 26 (2006) 9209-9219
10. Agou F., Traincard F., Vinolo E., Courtois G., Yamaoka S., Israel A., et al. The trimerization domain of NEMO is composed of the interacting C-terminal CC2 and LZ coiled-coil subdomains. J Biol Chem 279 (2004) 27861-27869
11. Wu C.J., Conze D.B., Li T., Srinivasula S.M., and Ashwell J.D. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kB activation. [corrected]. Nat Cell Biol 8 (2006) 398-406
12. Martinez-Pomar N., Munoz-Saa I., Heine-Suner D., Martin A., Smahi A., and Matamoros N. A new mutation in exon 7 of NEMO gene: late skewed X-chromosome inactivation in an incontinentia pigmenti female patient with immunodeficiency. Hum Genet 118 (2005) 458-465
13. Kosaki K., Shimasaki N., Fukushima H., Hara M., Ogata T., and Matsuo N. Female patient showing hypohidrotic ectodermal dysplasia and immunodeficiency (HED-ID). Am J Hum Genet 69 (2001) 664-666
14. Schmid J.M., Junge S.A., Hossle J.P., Schneider E.M., Roosnek E., Seger R.A., et al. Transient hemophagocytosis with deficient cellular cytotoxicity, monoclonal immunoglobulin M gammopathy, increased T-cell numbers, and hypomorphic NEMO mutation. Pediatrics 117 (2006) e1049-e1056
15. Dupuis-Girod S., Corradini N., Hadj-Rabia S., Fournet J.C., Faivre L., Le Deist F., et al. Osteopetrosis, lymphedema, anhidrotic ectodermal dysplasia, and immunodeficiency in a boy and incontinentia pigmenti in his mother. Pediatrics 109 (2002) e97
16. Mansour S., Woffendin H., Mitton S., Jeffery I., Jakins T., Kenwrick S., et al. Incontinentia pigmenti in a surviving male is accompanied by hypohidrotic ectodermal dysplasia and recurrent infection. Am J Med Genet 99 (2001) 172-177
17. Nishikomori R., Akutagawa H., Maruyama K., Nakata-Hizume M., Ohmori K., Mizuno K., et al. X-linked ectodermal dysplasia and immunodeficiency caused by reversion mosaicism of NEMO reveals a critical role for NEMO in human T-cell development and/or survival. Blood 103 (2004) 4565-4572
18. Orstavik K.H., Kristiansen M., Knudsen G.P., Storhaug K., Vege A., Eiklid K., et al. Novel splicing mutation in the NEMO (IKK-g) gene with severe immunodeficiency and heterogeneity of X-chromosome inactivation. Am J Med Genet A 140 (2006) 31-39
19. Smahi A., Courtois G., Vabres P., Yamaoka S., Heuertz S., Munnich A., et al. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature 405 (2000) 466-472
20. Risma K., Deering R., Monaco-Shawver L., Heltzer M., Burnham J., Niemela J., et al. Ectodermal dysplasia with immunodeficiency and lymphedema, but not osteopetrosis, is associated with a unique NF-κB essential modulator (NEMO) mutation. Clin Immunol 116 (2005) 300-301
21. Orange J.S., Levy O., and Geha R.S. Human disease resulting from gene mutations that interfere with appropriate nuclear factor-kappaB activation. Immunol Rev 203 (2005) 21-37
22. Niehues T., Reichenbach J., Neubert J., Gudowius S., Puel A., Horneff G., et al. Nuclear factor kappaB essential modulator-deficient child with immunodeficiency yet without anhidrotic ectodermal dysplasia. J Allergy Clin Immunol 114 (2004) 1456-1462
23. Orange J.S., Jain A., Ballas Z.K., Schneider L.C., Geha R.S., and Bonilla F.A. The presentation and natural history of immunodeficiency caused by nuclear factor κB essential modulator mutation. J Allergy Clin Immunol 113 (2004) 725-733
24. Salt B.H., Niemela J.E., Pandey R., Hanson E.P., Deering R.P., Quinones R., et al. IKBKG (nuclear factor-κB essential modulator) mutation can be associated with opportunistic infection without impairing TLR function. J Allergy Clin Immunol 121 (2007) 976-982
25. Orange J.S., Brodeur S.R., Jain A., Bonilla F.A., Schneider L.C., Kretschmer R., et al. Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations. J Clin Invest 109 (2002) 1501-1509
26. Dai Y.S., Liang M.G., Gellis S.E., Bonilla F.A., Scheider L.C., Geha R.S., et al. Characteristics of mycobacterial infection in patients with immunodeficiency and nuclear factor-kappaB essential modulator mutation, with or without ectodermal dysplasia. J Am Acad Dermatol 51 (2004) 718-722
27. Filipe-Santos O., Bustamante J., Haverkamp M.H., Vinolo E., Ku C.L., Puel A., et al. X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med 203 (2006) 1745-1759
28. Orange J.S., Levy O., Brodeur S.R., Krzewski K., Roy R.M., Niemela J.E., et al. Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia. J Allergy Clin Immunol 114 (2004) 650-656
29. Temmerman S.T., Ma C.A., Borges L., Kubin M., Liu S., Derry J.M., et al. Impaired dendritic-cell function in ectodermal dysplasia with immune deficiency is linked to defective NEMO ubiquitination. Blood 108 (2006) 2324-2331
30. Kabelitz D., and Medzhitov R. Innate immunity-cross-talk with adaptive immunity through pattern recognition receptors and cytokines. Curr Opin Immunol 19 (2007) 1-3
31. Kabelitz D. Expression and function of Toll-like receptors in T lymphocytes. Curr Opin Immunol 19 (2007) 39-45
32. Abinun M., Spickett G., Appleton A.L., Flood T., and Cant A.J. Anhidrotic ectodermal dysplasia associated with specific antibody deficiency. Eur J Pediatr 155 (1996) 146-147
33. Cordier F., Vinolo E., Veron M., Delepierre M., and Agou F. Solution structure of NEMO zinc finger and impact of an anhidrotic ectodermal dysplasia with immunodeficiency-related point mutation. J Mol Biol 377 (2008) 1419-1432
34. Nenci A., Becker C., Wullaert A., Gareus R., van Loo G., Danese S., et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 446 (2007) 557-561
35. Zaph C., Troy A.E., Taylor B.C., Berman-Booty L.D., Guild K.J., Du Y., et al. Epithelial-cell-intrinsic IKK-beta expression regulates intestinal immune homeostasis. Nature 446 (2007) 552-556